Functional status in older patients with lung cancer: an observational cohort study.
Aged
Cancer treatment protocols
Daily living activities
Functional status
Lung cancer
Mortality
Journal
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
ISSN: 1433-7339
Titre abrégé: Support Care Cancer
Pays: Germany
ID NLM: 9302957
Informations de publication
Date de publication:
May 2022
May 2022
Historique:
received:
28
06
2021
accepted:
09
12
2021
pubmed:
16
1
2022
medline:
26
3
2022
entrez:
15
1
2022
Statut:
ppublish
Résumé
An assessment of the impact of functional status (FS) evaluated using a combination of Activities of Daily Living (ADL) and the short version of the Instrumental Activities of Daily Living (IADL), on 3- and 6- month mortality and on 3-month unplanned hospitalizations in older patients treated for lung cancers. This observational retrospective study was conducted between September 2015 and January 2019 at Marseille University Hospital (AP-HM). During this period, all consecutive outpatients aged 70 years or older referred for a comprehensive geriatric assessment (CGA) before the initiation of lung cancer treatment were enrolled. Two hundred twenty-seven patients were analyzed: the median age was 78.7 years and 74.0% were male. Almost half of the patients were metastatic (45.4%). Concerning FS, 41.9% of patients had no ADL-IADL impairment, 30.0% had either IADL or ADL impairment, and both ADL-IADL were impaired for 28.1%. Impaired ADL-IADL was associated with poor nutritional status, depression, mobility, and cognitive disorders. In a logistic regression model, ADL or IADL impairment (aOR = 2.1; 95% CI [1.0-4.2]; p = 0.037) and impaired ADL-IADL (aOR = 2.6; 95% CI [1.2-5.3]; p = 0.012) were independently associated with a higher risk of unplanned hospitalizations within 3 months. In the multivariate Cox model, 6-month mortality risk was independently associated with impaired ADL-IADL (aHR = 2.3; 95% CI [1.3-4.4]; p = 0.008). The combination of ADL and IADL scales to assess FS is a prognostic marker of the mortality risk at 6 months in older patients with lung cancer and should be more largely used by oncologists in treatment decision making.
Identifiants
pubmed: 35031829
doi: 10.1007/s00520-021-06752-2
pii: 10.1007/s00520-021-06752-2
doi:
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
3817-3827Informations de copyright
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Owonikoko TK, Ragin CC, Belani CP et al (2007) Lung cancer in elderly patients: an analysis of the surveillance, epidemiology, and end results database. J Clin Oncol 25:5570–5577. https://doi.org/10.1200/JCO.2007.12.5435
doi: 10.1200/JCO.2007.12.5435
pubmed: 18065729
Howlader N, Noone AM, Krapcho M, Garshell J, Neyman N, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975–2010, National Cancer Institute. Bethesda, MD, https://seer.cancer.gov/archive/csr/1975_2010/ , based on November 2012 SEER data submission, posted to the SEER web site, April 2013. Accessed 14 Dec 2021
Giroux Leprieur E, Labrune S, Giraud V et al (2012) Delay between the initial symptoms, the diagnosis and the onset of specific treatment in elderly patients with lung cancer. Clin Lung Cancer 13:363–368. https://doi.org/10.1016/j.cllc.2011.11.010
doi: 10.1016/j.cllc.2011.11.010
pubmed: 22264658
Schulkes KJG, Hamaker ME, van den Bos F, van Elden LJR (2016) Relevance of a geriatric assessment for elderly patients with lung cancer-a systematic review. Clin Lung Cancer 17:341-349.e3. https://doi.org/10.1016/j.cllc.2016.05.007
doi: 10.1016/j.cllc.2016.05.007
pubmed: 27349507
Rivera C, Falcoz P-E, Bernard A et al (2011) Surgical management and outcomes of elderly patients with early stage non-small cell lung cancer: a nested case-control study. Chest 140:874–880. https://doi.org/10.1378/chest.10-2841
doi: 10.1378/chest.10-2841
pubmed: 21436251
Wildiers H, Heeren P, Puts M et al (2014) International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer. J Clin Oncol 32:2595–2603. https://doi.org/10.1200/JCO.2013.54.8347
doi: 10.1200/JCO.2013.54.8347
pubmed: 25071125
pmcid: 4876338
Mohile SG, Dale W, Somerfield MR et al (2018) Practical assessment and management of vulnerabilities in older patients receiving chemotherapy: ASCO guideline for geriatric oncology. J Clin Oncol 36:2326–2347. https://doi.org/10.1200/JCO.2018.78.8687
doi: 10.1200/JCO.2018.78.8687
pubmed: 29782209
pmcid: 6063790
Solomon DH (1988) Geriatric assessment: methods for clinical decision making. JAMA 259:2450–2452
doi: 10.1001/jama.1988.03720160070033
pubmed: 3280847
Aliamus V, Adam C, Druet-Cabanac M et al (2011) Geriatric assessment contribution to treatment decision-making in thoracic oncology. Rev Mal Respir 28:1124–1130. https://doi.org/10.1016/j.rmr.2011.04.012
doi: 10.1016/j.rmr.2011.04.012
pubmed: 22123138
Quoix E (2011) Optimal pharmacotherapeutic strategies for elderly patients with advanced non-small cell lung cancer. Drugs Aging 28:885–894. https://doi.org/10.2165/11595100-000000000-00000
doi: 10.2165/11595100-000000000-00000
pubmed: 22054229
Fiteni F, Anota A, Westeel V, Bonnetain F (2016) Methodology of health-related quality of life analysis in phase III advanced non-small-cell lung cancer clinical trials: a critical review. BMC Cancer 16:122. https://doi.org/10.1186/s12885-016-2152-1
doi: 10.1186/s12885-016-2152-1
pubmed: 26892541
pmcid: 4758022
Gridelli C, Balducci L, Ciardiello F et al (2015) Treatment of elderly patients with non-small-cell lung cancer: results of an international expert panel meeting of the Italian Association of Thoracic Oncology. Clin Lung Cancer 16:325–333. https://doi.org/10.1016/j.cllc.2015.02.006
doi: 10.1016/j.cllc.2015.02.006
pubmed: 25862554
Corre R, Greillier L, Le Caër H et al (2016) Use of a comprehensive geriatric assessment for the management of elderly patients with advanced non-small-cell lung cancer: the phase III randomized ESOGIA-GFPC-GECP 08–02 Study. J Clin Oncol 34:1476–1483. https://doi.org/10.1200/JCO.2015.63.5839
doi: 10.1200/JCO.2015.63.5839
pubmed: 26884557
Karampeazis A, Vamvakas L, Kotsakis A et al (2017) Docetaxel plus gemcitabine versus gemcitabine in elderly patients with advanced non-small cell lung cancer and use of a geriatric assessment: lessons from a prematurely closed Hellenic Oncology Research Group randomized phase III study. J Geriatr Oncol 8:23–30. https://doi.org/10.1016/j.jgo.2016.05.002
doi: 10.1016/j.jgo.2016.05.002
pubmed: 27264267
Ruiz J, Miller AA, Tooze JA et al (2019) Frailty assessment predicts toxicity during first cycle chemotherapy for advanced lung cancer regardless of chronologic age. J Geriatr Oncol 10:48–54. https://doi.org/10.1016/j.jgo.2018.06.007
doi: 10.1016/j.jgo.2018.06.007
pubmed: 30005982
Maestu I, Munoz J, Gomez-Aldaravi L et al (2007) Assessment of functional status, symptoms and comorbidity in elderly patients with advanced non-small-cell lung cancer (NSCLC) treated with gemcitabine and vinorelbine. Clin Transl Oncol 9:99–105. https://doi.org/10.1007/s12094-007-0019-2
doi: 10.1007/s12094-007-0019-2
pubmed: 17329221
Biesma B, Wymenga ANM, Vincent A et al (2011) Quality of life, geriatric assessment and survival in elderly patients with non-small-cell lung cancer treated with carboplatin-gemcitabine or carboplatin-paclitaxel: NVALT-3 a phase III study. Ann Oncol 22:1520–1527. https://doi.org/10.1093/annonc/mdq637
doi: 10.1093/annonc/mdq637
pubmed: 21252061
Decoster L, Kenis C, Schallier D et al (2017) Geriatric assessment and functional decline in older patients with lung cancer. Lung 195:619–626. https://doi.org/10.1007/s00408-017-0025-2
doi: 10.1007/s00408-017-0025-2
pubmed: 28634893
Couderc A-L, Boulahssass R, Nouguerede E et al (2019) Functional status in a geriatric oncology setting: a review. J Geriatr Oncol 10:884–894. https://doi.org/10.1016/j.jgo.2019.02.004
doi: 10.1016/j.jgo.2019.02.004
pubmed: 30824222
Katz S, Ford AB, Moskowitz RW et al (1963) Studies of illness in the aged. Index of ADL: A Standardized Measure of Biological and Psychosocial Function. JAMA 185:914–919
doi: 10.1001/jama.1963.03060120024016
pubmed: 14044222
Lawton MP, Brody EM (1969) Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 9:179–186
doi: 10.1093/geront/9.3_Part_1.179
pubmed: 5349366
Barberger-Gateau P, Dartigues JF, Letenneur L (1993) Four Instrumental Activities of Daily Living Score as a predictor of one-year incident dementia. Age Ageing 22:457–463
doi: 10.1093/ageing/22.6.457
pubmed: 8310892
Quoix E, Zalcman G, Oster J-P et al (2011) Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial. Lancet 378:1079–1088. https://doi.org/10.1016/S0140-6736(11)60780-0
doi: 10.1016/S0140-6736(11)60780-0
pubmed: 21831418
Soubeyran P, Bellera C, Goyard J et al (2014) Screening for vulnerability in older cancer patients: the ONCODAGE Prospective Multicenter Cohort Study. PLoS ONE 9:e115060. https://doi.org/10.1371/journal.pone.0115060
doi: 10.1371/journal.pone.0115060
pubmed: 25503576
pmcid: 4263738
Oken MM, Creech RH, Tormey DC et al (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649–655
doi: 10.1097/00000421-198212000-00014
pubmed: 7165009
Guigoz Y, Vellas B, Garry PJ (1994) Mini nutritional assessment: A practical assessment tool for grading the nutritional state of elderly patients. Facts and Research in Gerontology Issue SUPPL 2:15–59
Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198. https://doi.org/10.1016/0022-3956(75)90026-6
doi: 10.1016/0022-3956(75)90026-6
pubmed: 1202204
Yesavage JA (1988) Geriatric Depression Scale. Psychopharmacol Bull 24:709–711
pubmed: 3249773
Friedman PJ, Richmond DE, Baskett JJ (1988) A prospective trial of serial gait speed as a measure of rehabilitation in the elderly. Age Ageing 17:227–235. https://doi.org/10.1093/ageing/17.4.227
doi: 10.1093/ageing/17.4.227
pubmed: 3177082
Podsiadlo D, Richardson S (1991) The timed “Up & Go”: a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc 39:142–148. https://doi.org/10.1111/j.1532-5415.1991.tb01616.x
doi: 10.1111/j.1532-5415.1991.tb01616.x
pubmed: 1991946
Vellas BJ, Wayne SJ, Romero L et al (1997) One-leg balance is an important predictor of injurious falls in older persons. J Am Geriatr Soc 45:735–738. https://doi.org/10.1111/j.1532-5415.1997.tb01479.x
doi: 10.1111/j.1532-5415.1997.tb01479.x
pubmed: 9180669
Overcash JA, Rivera HR (2008) Physical performance evaluation of older cancer patients: a preliminary study. Crit Rev Oncol Hematol 68:233–241. https://doi.org/10.1016/j.critrevonc.2008.07.001
doi: 10.1016/j.critrevonc.2008.07.001
pubmed: 18789714
Puts MTE, Monette J, Girre V et al (2013) The fall rate of older community-dwelling cancer patients. Support Care Cancer 21:775–783. https://doi.org/10.1007/s00520-012-1579-4
doi: 10.1007/s00520-012-1579-4
pubmed: 22941117
Stone CA, Lawlor PG, Savva GM et al (2012) Prospective study of falls and risk factors for falls in adults with advanced cancer. J Clin Oncol 30:2128–2133. https://doi.org/10.1200/JCO.2011.40.7791
doi: 10.1200/JCO.2011.40.7791
pubmed: 22585687
Cruz-Jentoft AJ, Bahat G, Bauer J et al (2019) Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 48:601. https://doi.org/10.1093/ageing/afz046
doi: 10.1093/ageing/afz046
pubmed: 31081853
pmcid: 6593317
Miller MD, Paradis CF, Houck PR et al (1992) Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale. Psychiatry Res 41:237–248. https://doi.org/10.1016/0165-1781(92)90005-n
doi: 10.1016/0165-1781(92)90005-n
pubmed: 1594710
Wildes TM, Dua P, Fowler SA et al (2015) Systematic review of falls in older adults with cancer. J Geriatr Oncol 6:70–83. https://doi.org/10.1016/j.jgo.2014.10.003
doi: 10.1016/j.jgo.2014.10.003
pubmed: 25454770
Sattar S, Alibhai SMH, Spoelstra SL et al (2016) Falls in older adults with cancer: a systematic review of prevalence, injurious falls, and impact on cancer treatment. Support Care Cancer 24:4459–4469. https://doi.org/10.1007/s00520-016-3342-8
doi: 10.1007/s00520-016-3342-8
pubmed: 27450557
Sattar S, Haase K, Kuster S et al (2021) Falls in older adults with cancer: an updated systematic review of prevalence, injurious falls, and impact on cancer treatment. Support Care Cancer 29:21–33. https://doi.org/10.1007/s00520-020-05619-2
doi: 10.1007/s00520-020-05619-2
pubmed: 32671565
Pallis AG, Wedding U, Lacombe D et al (2010) Questionnaires and instruments for a multidimensional assessment of the older cancer patient: what clinicians need to know? Eur J Cancer 46:1019–1025. https://doi.org/10.1016/j.ejca.2010.01.006
doi: 10.1016/j.ejca.2010.01.006
pubmed: 20138506
Xue D, Han S, Jiang S et al (2015) Comprehensive geriatric assessment and traditional Chinese medicine intervention benefit symptom control in elderly patients with advanced non-small cell lung cancer. Med Oncol 32:114. https://doi.org/10.1007/s12032-015-0563-5
doi: 10.1007/s12032-015-0563-5
pubmed: 25772512
Maione P, Perrone F, Gallo C et al (2005) Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the elderly study. J Clin Oncol 23:6865–6872. https://doi.org/10.1200/JCO.2005.02.527
doi: 10.1200/JCO.2005.02.527
pubmed: 16192578
Kenis C, Decoster L, Bastin J et al (2017) Functional decline in older patients with cancer receiving chemotherapy: a multicenter prospective study. J Geriatr Oncol 8:196–205. https://doi.org/10.1016/j.jgo.2017.02.010
doi: 10.1016/j.jgo.2017.02.010
pubmed: 28330581
Kiesswetter E, Pohlhausen S, Uhlig K et al (2014) Prognostic differences of the Mini Nutritional Assessment short form and long form in relation to 1-year functional decline and mortality in community-dwelling older adults receiving home care. J Am Geriatr Soc 62:512–517. https://doi.org/10.1111/jgs.12683
doi: 10.1111/jgs.12683
pubmed: 24611678
Satin JR, Linden W, Phillips MJ (2009) Depression as a predictor of disease progression and mortality in cancer patients: a meta-analysis. Cancer 115:5349–5361. https://doi.org/10.1002/cncr.24561
doi: 10.1002/cncr.24561
pubmed: 19753617
Huo J, Hong Y-R, Xiao H, Wilkie D (2018) The impact of post-diagnosis depression on survival and healthcare costs for patients diagnosed with late-stage cancer in the United States. Value in Health 21:S25–S26. https://doi.org/10.1016/j.jval.2018.04.159
doi: 10.1016/j.jval.2018.04.159
Repetto L, Fratino L, Audisio RA et al (2002) Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study. J Clin Oncol 20:494–502. https://doi.org/10.1200/JCO.2002.20.2.494
doi: 10.1200/JCO.2002.20.2.494
pubmed: 11786579
Gajra A, Jatoi A (2014) Non–small-cell lung cancer in elderly patients: a discussion of treatment options. JCO 32:2562–2569. https://doi.org/10.1200/JCO.2014.55.3099
doi: 10.1200/JCO.2014.55.3099
Hoppe S, Rainfray M, Fonck M et al (2013) Functional decline in older patients with cancer receiving first-line chemotherapy. J Clin Oncol 31:3877–3882. https://doi.org/10.1200/JCO.2012.47.7430
doi: 10.1200/JCO.2012.47.7430
pubmed: 24062399